What it's for (Indications)
- This combination medication is primarily indicated for the symptomatic relief of pain and discomfort associated with hyperacidity conditions in the gastrointestinal tract.
- Specific indications include peptic ulcer disease (gastric and duodenal ulcers), esophagitis, reflux esophagitis, gastritis, heartburn, hiatal hernia, and other forms of dyspepsia where pain is a prominent feature.
- The oxethazaine component provides local anesthetic action, which is particularly beneficial in relieving pain originating from mucosal lesions or inflammation in the esophagus and stomach.
- This formulation aims to provide both immediate acid neutralization and prolonged pain relief, improving patient comfort and mitigating symptoms arising from excess stomach acid or mucosal irritation.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | Dosage typically involves taking 5-10 ml (1-2 teaspoonfuls) of the oral suspension 3-4 times daily, usually between meals and at bedtime, or as directed by a healthcare professional. It is crucial to shake the bottle well before each use to ensure uniform suspension and optimal distribution of active ingredients. The medication should ideally be taken undiluted for optimal local anesthetic effect of oxethazaine on the esophageal and gastric mucosa. Administration approximately 15 minutes before meals can help alleviate postprandial discomfort and heartburn. Pediatric dosing must be determined by a physician, considering the child's age, weight, and the specific gastrointestinal condition being treated. Adherence to the prescribed dosage and frequency is essential to maximize therapeutic benefits and minimize potential adverse effects. |
Safety & Warnings
Common Side Effects
- Common side effects are generally mild and transient, primarily related to the antacid components.
- These may include gastrointestinal disturbances such as constipation (more prominent with aluminium hydroxide) or diarrhea (more prominent with magnesium hydroxide), potentially leading to altered bowel habits.
- Nausea, vomiting, and abdominal cramping can also occur.
- The oxethazaine component, being a local anesthetic, can rarely cause a temporary numb sensation in the mouth or throat.
- Systemic effects like dizziness or drowsiness are rare but can occur if significant absorption of oxethazaine takes place.
- Prolonged use or high doses, especially in patients with renal impairment, can lead to more serious conditions like hypermagnesemia (muscle weakness, hypotension, respiratory depression) or aluminum toxicity (neurotoxicity, osteomalacia, hypophosphatemia).
- Allergic reactions are rare but possible.
Serious Warnings
- Black Box Warning: This specific combination product (aluminium hydroxide + magnesium hydroxide + oxethazaine) typically does not carry an FDA-mandated 'Black Box Warning'. However, due to the presence of active ingredients that can have significant systemic effects, especially with prolonged use or in vulnerable populations, a 'Serious Warnings' section detailing critical safety information is warranted.
- Patients should be advised not to exceed the recommended dosage or duration of treatment without medical supervision, especially due to the potential for systemic absorption of oxethazaine and the accumulation of aluminum or magnesium, particularly in individuals with compromised renal function.
- Caution is advised in patients with pre-existing kidney disease, as accumulation of aluminum and magnesium can lead to serious adverse effects including hypermagnesemia, aluminum toxicity, and osteomalacia.
- This medication may interfere with the absorption of other orally administered drugs, such as tetracyclines, fluoroquinolones, iron salts, digoxin, and thyroid hormones, requiring separation of administration times by at least 2-4 hours.
- Patients experiencing persistent or worsening symptoms, or the development of new symptoms, should consult a healthcare professional promptly.
- Pregnant or breastfeeding individuals should use this medication only under strict medical guidance after a thorough risk-benefit assessment.
How it Works (Mechanism of Action)
This medication exerts its therapeutic effects through a multi-pronged approach to address hyperacidity and associated pain. **Aluminium hydroxide** acts as a non-systemic antacid that neutralizes hydrochloric acid in the stomach, forming aluminum chloride and water, thereby increasing gastric pH and reducing pepsin activity. It also binds to phosphate in the gastrointestinal tract. **Magnesium hydroxide** also functions as a non-systemic antacid, neutralizing gastric acid to form magnesium chloride and water. Its osmotic properties can also contribute to a laxative effect. The combination of aluminium and magnesium hydroxides helps to balance the potential bowel effects (constipation from aluminum, diarrhea from magnesium). **Oxethazaine** is a potent topical local anesthetic that acts on nerve endings in the esophageal and gastric mucosa. It blocks the initiation and conduction of nerve impulses by decreasing the permeability of the neuronal membrane to sodium ions, thus stabilizing the membrane and preventing depolarization, which results in localized pain relief.
Commercial Brands (Alternatives)
No other brands found for this formula.